Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy

BACKGROUND: It is unclear whether asthma and asthma medications increase or decrease the risk of severe COVID-19, and this is particularly true for patients with severe asthma receiving biologics. OBJECTIVES: The aim of this study was to assess incidence and disease course of COVID-19 in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Eger, Katrien, Hashimoto, Simone, Braunstahl, Gert Jan, Brinke, Anneke ten, Patberg, Kornelis W., Beukert, Annelies, Smeenk, Frank, van der Sar–van der Brugge, Simone, Weersink, Els J.M., Bel, Elisabeth H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833566/
https://www.ncbi.nlm.nih.gov/pubmed/33388603
http://dx.doi.org/10.1016/j.rmed.2020.106287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833566/
https://www.ncbi.nlm.nih.gov/pubmed/33388603
http://dx.doi.org/10.1016/j.rmed.2020.106287

Ejemplares similares